Ferguson Strategies
Campaign Finance
$46,749 Given
Information
Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.
covers through 2011
-
Top Recipients
- Employee Color Block
- Individuals
- PAC Color Block
- PAC
-
Republicans vs. Democrats
in dollars -
State vs. Federal
in dollars -
Top PAC Recipients
- Employee Color Block
- Individuals
- PAC Color Block
- PAC
Lobbying
$230,000 Income
Information
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
covers through Q3, 2011
Lobbying Carried Out by Ferguson Strategies
-
Names of Lobbyists
-
Client Amount CR Bard Inc $90,000 Public Service Enterprise Group $60,000 Merck & Co $40,000 Medicines Co $30,000 Novartis Corp $10,000 -
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Energy & Nuclear Power,
- Taxes,
- Copyright, Patent & Trademark
-
Recent Lobbying Contracts
Date Client Summary May 3, 2012 Celgene Corp Policy issues relating to reauthorization of the Prescription Drug User Fee Act and implementation of the Patient Protection and Affordable Care Act (Public Law 111-148). View registration
